Charles Schwab Investment Management Inc. boosted its stake in Xometry, Inc. (NASDAQ:XMTR - Free Report) by 4.8% during the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 354,849 shares of the company's stock after buying an additional 16,396 shares during the quarter. Charles Schwab Investment Management Inc. owned approximately 0.72% of Xometry worth $6,519,000 as of its most recent filing with the SEC.
A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Connor Clark & Lunn Investment Management Ltd. purchased a new position in shares of Xometry in the 3rd quarter worth $355,000. Versor Investments LP purchased a new position in shares of Xometry in the 3rd quarter worth $411,000. ARK Investment Management LLC raised its position in shares of Xometry by 74.9% in the 2nd quarter. ARK Investment Management LLC now owns 264,937 shares of the company's stock worth $3,063,000 after buying an additional 113,478 shares during the period. Allspring Global Investments Holdings LLC raised its position in shares of Xometry by 191.1% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 216,700 shares of the company's stock worth $3,981,000 after buying an additional 142,262 shares during the period. Finally, Primecap Management Co. CA raised its position in shares of Xometry by 1.7% in the 3rd quarter. Primecap Management Co. CA now owns 6,918,252 shares of the company's stock worth $127,088,000 after buying an additional 113,264 shares during the period. Hedge funds and other institutional investors own 97.31% of the company's stock.
Xometry Stock Down 0.5 %
XMTR traded down $0.18 during trading on Thursday, reaching $34.59. The stock had a trading volume of 277,014 shares, compared to its average volume of 592,454. The company has a debt-to-equity ratio of 0.90, a quick ratio of 4.55 and a current ratio of 4.59. Xometry, Inc. has a 1-year low of $11.08 and a 1-year high of $38.74. The stock has a 50 day moving average of $25.72 and a two-hundred day moving average of $19.21.
Insider Activity
In other news, Director Emily Rollins sold 3,729 shares of the stock in a transaction on Thursday, November 7th. The stock was sold at an average price of $29.49, for a total transaction of $109,968.21. Following the completion of the sale, the director now owns 12,457 shares in the company, valued at approximately $367,356.93. This represents a 23.04 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CTO Matthew Leibel sold 3,400 shares of the business's stock in a transaction on Friday, September 13th. The shares were sold at an average price of $18.45, for a total transaction of $62,730.00. Following the sale, the chief technology officer now directly owns 82,918 shares in the company, valued at approximately $1,529,837.10. This trade represents a 3.94 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 41,633 shares of company stock worth $1,201,730. Insiders own 16.79% of the company's stock.
Analyst Upgrades and Downgrades
Several analysts recently issued reports on the company. UBS Group increased their price target on Xometry from $20.00 to $22.00 and gave the company a "neutral" rating in a report on Wednesday, November 6th. Cantor Fitzgerald reiterated an "underweight" rating and issued a $12.00 price target on shares of Xometry in a report on Wednesday, November 6th. Craig Hallum increased their price target on Xometry from $20.00 to $30.00 and gave the company a "buy" rating in a report on Wednesday, November 6th. JMP Securities raised their target price on Xometry from $34.00 to $42.00 and gave the company a "market outperform" rating in a research note on Thursday, November 14th. Finally, Citigroup raised their target price on Xometry from $25.00 to $33.00 and gave the company a "buy" rating in a research note on Wednesday, November 6th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and four have given a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average target price of $27.71.
View Our Latest Stock Report on Xometry
Xometry Profile
(
Free Report)
Xometry, Inc operates an online marketplace that enables buyers to source custom-manufactured parts and assemblies in the United States and internationally. It provides computer numerical control manufacturing, sheet metal forming, and sheet cutting; 3D printing, including fused deposition modeling, direct metal laser sintering, PolyJet, stereolithography, selective laser sintering, binder jetting, carbon digital light synthesis, multi jet fusion, and lubricant sublayer photo-curing; and die casting, stamping, injection molding, urethane casting, tube cutting, and tube bending, as well as finishing services, rapid prototyping, and high-volume production services.
Featured Stories
Before you consider Xometry, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xometry wasn't on the list.
While Xometry currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.